Trulieve Cannabis Misses Revenue Estimates on Weak Demand
(Reuters) -Trulieve Cannabis Corp posted a bigger-than-expected fall in first-quarter revenue on...
(Reuters) -Trulieve Cannabis Corp posted a bigger-than-expected fall in first-quarter revenue on...
By Ankit Kumar (Reuters) -Canopy Growth Corp said on Thursday it would shed assets in Canada and...
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ), a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce the receipt of a key importation licence for its Australian business. This licence is a critical step to building the Company’s […]
Minnesota Medical Solutions today announced that the Company has introduced a new product line of flavored oral sprays. MinnMed Oral Sprays will be offered in the most diverse range currently available in Minnesota. MinnMed is the only licensed cannabis producer in the State [...]
By Medha Singh and Lisa Pauline Mattackal (Reuters) – Things are heating up on the bitcoin...
(Reuters) – Shares of crypto currency- and blockchain-related companies fell in premarket...
(Reuters) -Cryptocurrency exchange Coinbase Global Inc posted a smaller-than-expected...
By Medha Singh and Lisa Pauline Mattackal (Reuters) – Beleaguered bitcoin miners are finally...
(Reuters) – U.S. chemical maker Dow Inc said on Thursday it had signed a long-term supply...
Therapies that entail removing immune cells from patients and engineering them to recognize and fight cancer have revolutionized the treatment of some blood cancers, but they’ve proven difficult to translate to other [...]
Roche has dropped an antisense hepatitis B drug shortly after licensing a rival therapy from Dicerna Pharmaceuticals. RG6004 fell off Roche’s pipeline as part of a periodic cull that affected a handful of other experimental programs. Synthetic locked nucleic acid modified antisense oligonucleotide RG6004 moved into the clinic early in 2017, opening [...]
A new report out of the U.K. has spotlighted the continuing opacity of clinical trial reporting, with nearly 60% of more than 4,200 studies not showing results within a year, as mandated by new rules in the U.S. Researchers from the University of Oxford led by transparency [...]
By Ahmad Ghaddar and Maha El Dahan LONDON/DUBAI (Reuters) – OPEC and its allies are unlikely...
By Nerijus Adomaitis BERGEN, Norway (Reuters) – Inspections of Norway’s offshore gas...
By Mike Stone CAMDEN, Arkansas (Reuters) – Lockheed Martin’s mobile rocket launcher...
BILLY-BERCLAU, France (Reuters) -Stellantis will need one or even two additional large factories...
By Clara Denina and Helen Reid LONDON (Reuters) – Mining firms lag far behind other sectors...
By Nelson Banya and Felix Njini (Reuters) -Gold miner AngloGold Ashanti will move its primary...
(Reuters) – Canadian miner Barrick Gold Corp beat Wall Street expectations for first-quarter...
By Fabian Cambero SANTIAGO (Reuters) -While Chile’s plan to take control of its lithium...
FRANKFURT (Reuters) – Volkswagen will start selling battery-powered versions of its VW bus...
By Joyce Lee and Brenda Goh SEOUL/SHANGHAI (Reuters) -A move by Beijing to bar U.S. firm Micron...
By Munsif Vengattil and Aditya Kalra NEW DELHI (Reuters) – Tesla Inc is...
WASHINGTON (Reuters) – Ford Motor Co is recalling 422,000 sport utility vehicles in the U.S....